Every day, Global University Venturing rounds up investments from across the university innovation ecosystem in its deal net.

CoreMap, a US-based developer of a cure for atrial fibrillation spun out of University of Vermont, has concurrently completed a $3m series A extension and $20m series B round from undisclosed strategic, institutional, venture and individual investors. CoreMap previously raised an initial $10.5m in series A financing led by Qure Ventures, with participation from The Fund at Hula, in September 2020.

Odaia, a Canada-based commercial insights platform aimed at pharmaceutical firms based on University of Toronto research, has obtained $13.8m…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.



Not sure if you have a subscription?
Thierry Heles

Thierry Heles is the editor of Global University Venturing, host of the Beyond the Breakthrough interview podcast and responsible for the monthly GUV Gazette (sign up here for free).
email Linked in